Latest Kaiser Health News Stories
Although service dogs are commonly seen at the Uniformed Services University of the Health Sciences, a retriever mix is a clinical instructor in the Department of Medical and Clinical Psychology.
Nearly 8 in 10 Americans say the cost of prescription drugs is unreasonable, but the odds look grim for Congress to pass significant pricing legislation this year.
Doctors are less likely to prescribe opioids in Germany and quicker to notice if a patient is at risk of abuse. And, for those who do experience addiction, treatment is easier to come by.
Kaiser Permanente just avoided a nationwide strike by thousands of workers, but now faces a new strike threat Monday. The labor battles are exposing the health care giant to scrutiny from lawmakers, health care advocates and others who accuse it of no longer living up to its nonprofit ideals.
KHN’s Shefali Luthra discusses the recent Trump administration lawsuit regarding the HIV-prevention drug Truvada.
Key Democratic wins in 2019 state elections in Virginia and (probably) Kentucky could have big implications for health care in general and Medicaid in particular. And in the Democratic presidential primary, Elizabeth Warren is catching flak from all sides over her “Medicare For All” plan. This week, Joanne Kenen of Politico, Caitlin Owens of Axios and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss these issues and more. Plus, Rovner interviews KHN’s Laura Ungar, who wrote the latest KHN-NPR “Bill of the Month.” For “extra credit,” the panelists recommend their favorite health stories of the week.
CBS This Morning reports on the latest KHN-NPR Bill of the Month.
Patients were thrilled last month when UVA announced it would scale back lawsuits and provide more financial assistance, but the excitement has waned.
A few hundred hospitals have banded together to sue drugmakers in state courts, but far more are staying on the sidelines to avoid ‘unflattering attention’ about their role in the opioid crisis.
Katie West, an American health researcher who has lived in Germany the past three years, hasn’t mastered the language and misses her family. But not having to worry about the cost of her lifesaving medication makes it OK.
Manufacturers of lucrative drugs say they’re offering discounts off the high sticker prices ― but taxpayers footing the big bills might never know what the state is paying or if it’s getting a good deal.
Companies are aggressively touting 3D mammograms, although there’s no evidence they save lives.
A lawsuit against Group Health surfaces as the White House promotes Medicare Advantage for seniors.
A letter from the Senate Finance Committee chairman questions the University of Virginia Health System about its financial assistance policies, billing practices and prices.
In what experts call an “epidemic of immobility,” older hospital patients remain stuck in bed, their movements tracked by loud and ineffective bed alarms, losing muscle mass that’s key to their health and daily functioning.
Sutter Health has reached a tentative settlement in an antitrust suit brought by the California Attorney General’s Office. Details have not been made public.